Spectrum Pharmaceuticals Inc
SPPI
SPPI was delisted on the 31st of July, 2023.
146 hedge funds and large institutions have $297M invested in Spectrum Pharmaceuticals Inc in 2015 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 58 increasing their positions, 39 reducing their positions, and 23 closing their positions.
247% more call options, than puts
Call options by funds: $111K | Put options by funds: $32K
49% more repeat investments, than reductions
Existing positions increased: 58 | Existing positions reduced: 39
4% less first-time investments, than exits
New positions opened: 22 | Existing positions closed: 23
1% less funds holding
Funds holding: 148 → 146 (-2)
7% less capital invested
Capital invested by funds: $318M → $297M (-$21.3M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Acadian Asset Management
Boston,
Massachusetts
|
+$11.3M |
| 2 |
Renaissance Technologies
New York
|
+$4.68M |
| 3 |
RFC
Russell Frank Company
Seattle,
Washington
|
+$3.62M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.77M |
| 5 |
D.E. Shaw & Co
New York
|
+$2.73M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BC
Broadfin Capital
New York
|
-$15.1M |
| 2 |
State Street
Boston,
Massachusetts
|
-$12.1M |
| 3 |
ACA
Avoro Capital Advisors
New York
|
-$7.87M |
| 4 |
ACM
Ashford Capital Management
Wilmington,
Delaware
|
-$7.32M |
| 5 |
NI
Numeric Investors
Boston,
Massachusetts
|
-$3.45M |
SPPI Hedge Fund Activity: Q4 2015 in Review
146 of the 3,824 institutional investors tracked by Wall St. Rank reported a position in Spectrum Pharmaceuticals Inc (SPPI) for Q4 2015, worth a combined $297M — down 6.7% from $318M a quarter earlier.
Sellers outnumbered buyers: 23 funds closed out of SPPI and 22 opened new positions — a net loss of 1 holder — while 39 trimmed existing stakes and 58 added.
The largest buyer was Acadian Asset Management, adding an estimated $11.3M. The largest seller was Broadfin Capital, exiting entirely with an estimated $15.1M sold.
- 146 institutional investors held Spectrum Pharmaceuticals Inc (SPPI) as of Q4 2015, down from 148 in Q3 2015.
- Funds reported $297M of Spectrum Pharmaceuticals Inc stock for Q4 2015, down 6.7% quarter-over-quarter.
- 22 funds opened new Spectrum Pharmaceuticals Inc positions in Q4 2015 and 23 closed out, a net change of -1 holder.
- The largest Spectrum Pharmaceuticals Inc buyer in Q4 2015 was Acadian Asset Management, an estimated $11.3M added.
- The largest Spectrum Pharmaceuticals Inc seller in Q4 2015 was Broadfin Capital, an estimated $15.1M sold.
Based on aggregated 13F filings for Q4 2015.